We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Two NDAs for Lundbeck’s Sabril
FDA Approves Two NDAs for Lundbeck’s Sabril
August 28, 2009
The FDA has approved two NDAs for H. Lundbeck’s Sabril treatment for infantile spasms and also has granted approval for the drug to treat complex partial seizures.